KRISTIN DAVIS: Open Payments
NPI 1285364109 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 115 payments from 18 companies in 2025. Trend: 2023 $708 · 2024 $1,545 · 2025 $2,028
Food & beverage: $1,947Education: $82
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $478 |
| GENZYME CORPORATION | 8 | $293 |
| Janssen Biotech, Inc. | 18 | $293 |
| Regeneron Healthcare Solutions, Inc. | 9 | $236 |
| UCB, Inc. | 26 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Lilly USA, LLC | 3 | $75 |
| Incyte Corporation | 4 | $70 |
| PFIZER INC. | 3 | $55 |
| Organogenesis Inc. | 1 | $41 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Bimzelx, COSENTYX, OPZELURA, TALTZ.
Industry payments across GA — which companies pay providers there.
